Rocky Mountain spotted fever medical therapy

Revision as of 20:12, 11 January 2016 by Ilan Dock (talk | contribs)
Jump to navigation Jump to search

Rocky Mountain spotted fever Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Causes

Differentiating Rocky Mountain spotted fever from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Chest X-Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Rocky Mountain spotted fever medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rocky Mountain spotted fever medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rocky Mountain spotted fever medical therapy

CDC on Rocky Mountain spotted fever medical therapy

Rocky Mountain spotted fever medical therapy in the news

Blogs on Rocky Mountain spotted fever medical therapy

Directions to Hospitals Treating Rocky Mountain spotted fever

Risk calculators and risk factors for Rocky Mountain spotted fever medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

The mainstay of therapy for rocky mountain spotted fever is doxycycline. Pharmacologic therapy for rocky mountain spotted fever includes either Doxycycline or Chloramphenicol.

Medical Therapy

  • Doxycycline is the mainstay of therapy for Rocky Mountain spotted fever. Use of antibiotics other than doxycycline is associated with a higher risk of fatal outcome.
  • Treatment is most effective at preventing death if doxycycline is started in the first 5 days of symptoms.
  • Empirical antibiotic therapy should be initiated immediately when there is a suspicion of Rocky Mountain spotted fever on the basis of clinical and epidemiologic findings.
  • Treatment should not be delayed until laboratory confirmation is obtained.
  • If the patient is treated within the first 4-5 days of the disease, fever generally subsides within 24-72 hours.
  • Failure to respond to doxycycline argues against a diagnosis of RMSF.
  • Severely ill patients may require longer periods before their fever resolves, especially if they have experienced damage to multiple organ systems.
  • Preventive therapy in non-ill patients who have had recent tick bites is not recommended and may, in fact, only delay the onset of disease. [1]

Antimicrobial regimens

  • Rocky Mountain spotted fever[1]
  • 1. Adults
  • Preferred regimen: Doxycycline 100 mg PO q12h for 7-14 days
  • Note: Treatment with antibiotic agents other than doxycycline is associated with worse outcomes.
  • 2. Children under 45kg
  • Preferred regimen: Doxycycline 2.2 mg/kg PO q12h for 7-14 days

References

  1. 1.0 1.1 Rocky Mountain Spotted Fever Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/rmsf/symptoms/index.html Accessed on December 30, 2015